Recall Register

Food, drugs, devices › Siemens Healthcare Diagnostics Inc

Device recall: RAPIDPoint 500 Blood Gas Analyzer, Siemens Material Numbers (SMN):10492730, 10696855, 10696857, 10697306 This system tes

FDA enforcement event 71840 · Class II · initiated 28 Jul 2015 · status Terminated · terminated 17 Feb 2017

DeviceVoluntary: Firm initiated1 product recordNorwood, MA

FDA enforcement event 71840 is a device recall by Siemens Healthcare Diagnostics Inc of Norwood, MA, initiated 28 Jul 2015 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 17 Feb 2017. Initiation: voluntary: firm initiated. Siemens Healthcare Diagnostics Inc has 333 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Siemens Healthcare Diagnostics Inc, Norwood, MA.

Reason for recall

"When both ports (Serial and Ethernet) are configured to transmit data, the data stream from one port could potentially affect the data stream from the other port causing the data management system to include either: duplicate data, missing data, or data from a different patient."

Distribution

"Worldwide Distribution - US (nationwide) Distribution and to the countries of : Albania, Algeria, Armenia, Australia, Austria, Bahrain, Bangladesh, Belgium, Bosnia Herzeg, Brazil, Bulgaria,Canada,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2479-2015RAPIDPoint 500 Blood Gas Analyzer, Siemens Material Numbers (SMN):10492730, 10696855, 10696857, 10697306 This system tests blood gases, electrolytes, metabolites, total hemoglobin, and hemoglobin derivatives in arterial, venous, and capillary whole blood samples.5241 unitsClass IITerminated9 Sep 2015

Context

91%of 2015 device events are Class II1,153 events that year
1product record in this eventfirm median: 1
333events on this register for the firm

Other enforcement events for Siemens Healthcare Diagnostics Inc

InitiatedProduct (first record)TypeClassRecords
13 Jul 2026Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLDeviceClass II2
6 Jul 2026Atellica CH Urine Albumin REF: 11537225, in vitro diagnosticDeviceClass II1
26 Jun 2026Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULDeviceClass III1
26 Jun 2026Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370 Catalog No 6N319ULDeviceClass III1
8 Jun 2026Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.DeviceClass II1
7 May 2026Siemens Dimension Tacrolimus Flex Reagent Cartridge (TAC), REF DF207, SMN 10700795; enzyme immunoassayDeviceClass II1
2 Apr 2026epoc BGEM BUN Test Card (25 pk) for the epoc Blood Analysis System; Siemens Material Number (SMN): 10736515;DeviceClass II1
18 Mar 2026Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.DeviceClass II1
23 Feb 2026Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536;DeviceClass II1
20 Jan 2026Atellica CH Urine Albumin (UAlb). Material Number: 11537225DeviceClass II1

All 333 events for Siemens Healthcare Diagnostics Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "When both ports (Serial and Ethernet) are configured to transmit data, the data stream from one port could potentially affect the data stream from the other port causing the data management system to include either: duplicate data, missing data, or data from a different patient."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - US (nationwide) Distribution and to the countries of : Albania, Algeria, Armenia, Australia, Austria, Bahrain, Bangladesh, Belgium, Bosnia Herzeg, Brazil, Bulgaria,Canada,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 17 Feb 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.